Clinical Indication

For treating active autoantibody positive systemic lupus erythematosus


In line with NICE TA752.

Implementation date 15th March 2022

Date of classification

February 2022


Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.